Studies reveal that key UPR components, including ATF6 and sXBP1, are progressively downregulated in β-cells of both mouse models and human T1D patients, implicating UPR dysfunction in the disease process (Engin et al., 2013). The gene discussed is ATF6; the disease is type 1 diabetes mellitus.